A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7|[sol]|DOX breast cancer cells

摘要

Background:Breast cancer is the most common malignancy in women. Although chemotherapeutic agents, such as paclitaxel, are effective treatments for the majority of breast cancer patients, recurrence is frequent and often leads to death. Thus, there is an urgent need to identify novel therapeutic targets that sensitise tumour cells to existing chemotherapy agents.